Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lung Capacity01:47

Lung Capacity

56.2K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Other Nuclides: 31P, 19F, 15N NMR01:16

Other Nuclides: 31P, 19F, 15N NMR

777
Many organic, inorganic, and biological molecules contain spin-half nuclei such as nitrogen-15, fluorine-19, and phosphorus-31. As a result, NMR studies of these nuclei have found extensive applications in chemical and biological research.
While fluorine-19 and phosphorous-31 have high natural abundances (100%) and positive gyromagnetic ratios, nitrogen-15 has a low natural abundance and a negative gyromagnetic ratio. However, nitrogen-15 is still preferred over nitrogen-14 (which has a...
777
Pleura of the Lungs01:13

Pleura of the Lungs

7.1K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
7.1K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.0K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.0K
Gross Anatomy of the Lungs01:17

Gross Anatomy of the Lungs

4.7K
The lungs are a pair of vital organs connected to the trachea via the left and right bronchi. The base of these organs meets the dome-shaped muscle known as the diaphragm. Encased by the pleurae, the lungs contact the mediastinum. The right lung is shorter yet wider, and has a larger volume than the left lung. The left lung has an indentation known as the cardiac notch. The superior region of the lungs is referred to as the apex, whereas the base is the lower region near the diaphragm. The...
4.7K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metered cryospray in patients with chronic bronchitis: a mechanistic randomised controlled study.

Thorax·2026
Same author

Investigating the lasting effects of SARS-CoV-2 infection and the lung microbiome: no persistent microbial alterations in recovered COVID-19 patients with persistent radiological or respiratory abnormalities.

Access microbiology·2026
Same author

Editorial: Deciphering the microbiome's role in the progression of interstitial lung diseases.

Frontiers in medicine·2026
Same author

Establishing the top 10 research priorities for lung volume reduction treatment for people with COPD.

Thorax·2026
Same author

Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.

American journal of respiratory and critical care medicine·2026
Same author

Bronchial Thermoplasty Induced Changes in Blood Transcriptome Profile of Patients with Severe Asthma.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Jan 29, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.8K

COVID-19 and Interstitial Lung Disease.

Roberto G Carbone1, Sharada Nagoti2, Assaf Monselise3

  • 1Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy.

Medicina (Kaunas, Lithuania)
|January 28, 2026
PubMed
Summary

Interstitial lung disease (ILD) is a major long-term complication of COVID-19, causing lung fibrosis and reduced function. Management is evolving, with ongoing research into better diagnostics and treatments for this chronic condition.

Keywords:
COVIDILDSARS-CoV-2antifibrotic drugshigh resolution chest computed tomographyidiopathic pulmonary fibrosisinterstitial lung diseaselung cryobiopsypost-COVID ILD

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.2K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.4K

Related Experiment Videos

Last Updated: Jan 29, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.8K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.2K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.4K

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Pathology

Background:

  • COVID-19, caused by SARS-CoV-2, can lead to serious complications.
  • Interstitial lung disease (ILD) is a significant long-term consequence, characterized by progressive lung fibrosis and impaired respiratory function.

Purpose of the Study:

  • To provide an updated narrative review on post-COVID-19 ILD.
  • To examine research publications and clinical guidelines from 2020-2025.

Main Methods:

  • Diagnosis involves medical history, physiological examination, pulmonary function tests, and imaging (HRCT).
  • Lung biopsy (cryobiopsy or VATS) may be used for histological confirmation.

Main Results:

  • Post-COVID-19 ILD presents as a chronic condition with persistent respiratory symptoms, radiological findings, and reduced lung function.
  • Risk factors include severe acute illness, advanced age, male sex, and smoking. Prognosis varies, with some patients improving and others declining.
  • Current treatments include corticosteroids, antifibrotics (e.g., nerandomilast), oxygen support, pulmonary rehabilitation, smoking cessation, and vaccination.

Conclusions:

  • ILD is a significant long-term complication of COVID-19.
  • Further research is needed to elucidate pathophysiology and optimize clinical management.
  • Emerging diagnostic and therapeutic strategies are anticipated.